-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BI-836880 in Oral Cavity (Mouth) Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BI-836880 in Oral Cavity (Mouth) Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.BI-836880 in Oral Cavity (Mouth) CancerDrug Details:BI-836880 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CCAR-039 in Primary Mediastinal B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CCAR-039 in Primary Mediastinal B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CCAR-039 in Primary Mediastinal B-Cell Lymphoma Drug Details: CCAR-039...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Durvalumab in Anaplastic Large Cell Lymphoma (ALCL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Durvalumab in Anaplastic Large Cell Lymphoma (ALCL) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Durvalumab in Anaplastic Large Cell Lymphoma (ALCL) Drug Details:...
-
Product Insights
Quarterly Cheese pricing trends in Poland
Consumers' preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices. GlobalData's new report titled "Quarterly Cheese pricing trends in Poland" serves as a crucial resource for analyzing pricing...
-
Product Insights
Huntington Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Huntington's disease (HD) is an inherited disease that causes certain nerve cells in the brain to waste away. This is a familial disease that is passed on from parent to child through a mutation in their genes. Early symptoms of HD include uncontrolled movements, clumsiness, and balance problems. Later, HD can take away the ability to walk, talk, and swallow. The Huntington Disease pipeline market research report provides comprehensive information on the therapeutics under development for Huntington Disease (Central Nervous...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – nabilone
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry nabilone Drug Details Nabilone is under development for the treatment of pain. It is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – selisistat
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry selisistat Drug Details Selisistat is under development for the treatment of Huntington's disease. The...
-
Product Insights
Polycythemia Vera Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Polycythemia Vera pipeline market research report provides comprehensive information on the therapeutics under development for Polycythemia Vera, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Polycythemia Vera and features dormant and...
-
Product Insights
Tachycardia (Tachyarrhythmias) – Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Tachycardia (Tachyarrhythmias) - Global Clinical Trials Review, H2, 2021" provides an overview of Tachycardia (Tachyarrhythmias) Clinical trials scenario. This report provides top line data relating to the clinical trials on Tachycardia (Tachyarrhythmias). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides...
-
Product Insights
Atrial Flutter – Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Atrial Flutter - Global Clinical Trials Review, H2, 2021" provides an overview of Atrial Flutter Clinical trials scenario. This report provides top line data relating to the clinical trials on Atrial Flutter . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...